We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$916M
AUM Growth
+$892K
Cap. Flow
-$20.5M
Cap. Flow %
-2.24%
Top 10 Hldgs %
28.98%
Holding
377
New
21
Increased
75
Reduced
140
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 19.01%
2 Financials 14.23%
3 Consumer Discretionary 7.7%
4 Healthcare 6.79%
5 Communication Services 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
101
AT&T
T
$177B
$1.98M 0.22%
79,656
-25,726
-24% -$651K
PATK icon
102
Patrick Industries
PATK
$2.69B
$1.97M 0.22%
18,214
R icon
103
Ryder
R
$9.57B
$1.97M 0.22%
10,286
-64
-0.6% -$11.5K
WELL icon
104
Welltower
WELL
$174B
$1.92M 0.21%
10,332
+2,517
+32% +$470K
HALO icon
105
Halozyme
HALO
$12.2B
$1.79M 0.2%
26,562
-10,954
-29% -$737K
IBDR icon
106
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.35B
$1.78M 0.19%
+73,593
New +$1.78M
CSCO icon
107
Cisco
CSCO
$443B
$1.76M 0.19%
22,912
+545
+2% +$40.4K
LNG icon
108
Cheniere Energy
LNG
$58.7B
$1.76M 0.19%
9,078
-64
-0.7% -$13.4K
GLD icon
109
SPDR Gold Trust
GLD
$153B
$1.7M 0.19%
4,298
-257
-6% -$98.1K
SPSB icon
110
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.5B
$1.69M 0.18%
55,871
+4,060
+8% +$123K
UTHR icon
111
United Therapeutics
UTHR
$22.2B
$1.65M 0.18%
3,391
+1,015
+43% +$473K
CI icon
112
Cigna
CI
$74.2B
$1.64M 0.18%
5,960
-2,349
-28% -$659K
NUKZ icon
113
Range Nuclear Renaissance Index ETF
NUKZ
$789M
$1.55M 0.17%
24,464
+17,119
+233% +$1.15M
INVA icon
114
Innoviva
INVA
$1.54B
$1.54M 0.17%
77,157
DE icon
115
Deere & Co
DE
$171B
$1.52M 0.17%
3,271
-865
-21% -$406K
SCHF icon
116
Schwab International Equity ETF
SCHF
$69.7B
$1.5M 0.16%
62,323
+13,948
+29% +$332K
NEE icon
117
NextEra Energy
NEE
$176B
$1.5M 0.16%
18,644
-307
-2% -$25.4K
VEU icon
118
Vanguard FTSE All-World ex-US ETF
VEU
$70.7B
$1.5M 0.16%
20,334
+4,572
+29% +$332K
HCA icon
119
HCA Healthcare
HCA
$92.5B
$1.49M 0.16%
+3,190
New +$1.48M
VWO icon
120
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$1.49M 0.16%
27,649
+111
+0.4% +$6.03K
IWC icon
121
iShares Micro-Cap ETF
IWC
$1.52B
$1.48M 0.16%
+9,403
New +$1.46M
VCLT icon
122
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.85B
$1.48M 0.16%
19,469
-558
-3% -$43.1K
IBDS icon
123
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.9B
$1.47M 0.16%
60,428
+241
+0.4% +$5.86K
IBMO icon
124
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
$556M
$1.42M 0.16%
55,435
-3,920
-7% -$100K
AGZ icon
125
iShares Agency Bond ETF
AGZ
$571M
$1.41M 0.15%
12,797
-716
-5% -$79.1K

Similar funds

James Investment Research's Q4 2025 Portfolio in Review

As of Q4 2025, James Investment Research held 377 positions worth $916M, up 0.1% from $915M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

James Investment Research's Q4 2025 filing shows 21 new, 75 increased, 140 reduced and 16 closed positions. Its largest new stake was Fox Class B: 39,859 shares worth $2.59M. The largest sale was NVIDIA, an estimated $3.85M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • James Investment Research's largest Q4 2025 buy was Fox Class B: 39,859 shares worth $2.59M.
  • James Investment Research added most to iShares Floating Rate Bond ETF in Q4 2025, an estimated $2.38M increase.
  • James Investment Research's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.85M.
  • James Investment Research fully exited Republic Services in Q4 2025, selling an estimated $1.64M.
  • James Investment Research's ten largest holdings make up 29% of its $916M portfolio in Q4 2025.
  • James Investment Research opened 21 new positions and closed 16 in Q4 2025.
  • James Investment Research's portfolio value rose 0.1% quarter-over-quarter to $916M.

Based on James Investment Research's 13F filing for Q4 2025, filed 29 Jan 2026.